Tools

LEADER 03361cam 22004817i 4500

001 ssj0002031025;

003 WaSeSS;

005 20220112082112.0;

006 m d ;

007 cr n ;

008 180524s2017 dcua sb 000 0 eng d;

010 a| 2018300171;

020 a| 9780309455626 (pbk.);

020 a| 0309455626;

035 a| (WaSeSS)ssj0002031025;

042 a| lccopycat;

049 a| EREEa| NEHH;

050 00 a| R723.7b| .D687 2017;

082 00 a| 610.2852| 23;

100 1 a| Downey, Autumn S.=| ^A1330427;

245 10 a| Real-world evidence generation and evaluation of therapeuticsh| [electronic resource] :b| proceedings of a workshop /c| Autumn Downey, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Health and Medicine Division, The National Academies of Sciences, Engineering, Medicine.;

260 a| Washington, DC :b| The National Academies Press,c| [2017];

300 a| xvi, 85 pages :b| color illustrations ;c| 23 cm;

504 a| Includes bibliographical references.;

506 a| Available only to authorized users.;

520 a| "The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the context of this wealth of real-world data could be numerous and varied, ranging from the ability to determine both large-scale and patient-specific effects of treatments to the ability to assess how therapeutics affect patients' lives through measurement of lifestyle changes. In October 2016, the National Academies of Sciences, Engineering, and Medicine held a workshop to facilitate dialogue among stakeholders about the opportunities and challenges for incorporating real-world evidence into all stages in the process for the generation and evaluation of therapeutics. Participants explored unmet stakeholder needs and opportunities to generate new kinds of evidence that meet those needs. This publication summarizes the presentations and discussions from the workshop"--c| Publisher's description.;

538 a| Mode of access: World Wide Web;

650 0 a| Evidence-based medicinex| Data processingv| Congresses.=| ^A473575;

655 0 a| Electronic books.=| ^A491897;

700 1 a| Gee, Amanda Wagner.=| ^A1364321;

700 1 a| Claiborne, Anne B.=| ^A1108281;

710 2 a| National Academies of Sciences, Engineering, and Medicine (U.S.).b| Forum on Drug Discovery, Development, and Translation.=| ^A1363330;

856 40 z| Full text available from Ebook Central - Academic Completeu| https://ebookcentral.proquest.com/lib/eastcarolina/detail.action?docID=4908139;

947 a| (OCoLC)ocn973754834;

949 a| CLICK ON WEB ADDRESSw| ASISh| JOYNER188;

949 a| CLICK ON WEB ADDRESSw| ASISh| HSL77;

949 a| CLICK ON WEB ADDRESSw| ASISh| JMUSIC60;

596 a| 1 3 4;

998 a| 5567108;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5567108-1001l| JNETm| JOYNERr| Ys| Yt| JNESSBKu| 2/19/2021x| EBOOKz| JERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5567108-2001l| HSLELECm| HSLr| Ys| Yt| HEBKu| 2/19/2021x| EBOOKz| HERESOURCE;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 5567108-3001l| MNETm| JMUSICr| Ys| Yt| MNESSBKu| 2/19/2021x| EBOOKz| JERESOURCE;

Real-world evidence generation and evaluation of therapeutics proceedings of a workshop / Autumn Downey, Amanda Wagner Gee, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Health and Medicine Division, The National Academies of Sciences, Engineering, Medicine.

Author/creator	Downey, Autumn S.
Other author	Gee, Amanda Wagner.
Other author	Claiborne, Anne B.
Other author	National Academies of Sciences, Engineering, and Medicine (U.S.). Forum on Drug Discovery, Development, and Translation.
Format	Electronic
Publication Info	Washington, DC : The National Academies Press, [2017]
Description	xvi, 85 pages : color illustrations ; 23 cm
Supplemental Content	Full text available from Ebook Central - Academic Complete
Subjects	Evidence-based medicine--Data processing. --Congresses.

Abstract	"The volume and complexity of information about individual patients is greatly increasing with use of electronic records and personal devices. Potential effects on medical product development in the context of this wealth of real-world data could be numerous and varied, ranging from the ability to determine both large-scale and patient-specific effects of treatments to the ability to assess how therapeutics affect patients' lives through measurement of lifestyle changes. In October 2016, the National Academies of Sciences, Engineering, and Medicine held a workshop to facilitate dialogue among stakeholders about the opportunities and challenges for incorporating real-world evidence into all stages in the process for the generation and evaluation of therapeutics. Participants explored unmet stakeholder needs and opportunities to generate new kinds of evidence that meet those needs. This publication summarizes the presentations and discussions from the workshop"-- Publisher's description.
Bibliography note	Includes bibliographical references.
Access restriction	Available only to authorized users.
Technical details	Mode of access: World Wide Web
Genre/form	Electronic books.
LCCN	2018300171
ISBN	9780309455626 (pbk.)
ISBN	0309455626

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Click here for more information about this title

Availability